Context Therapeutics
Price & Volume
Stats
See more52W Range | $0.56-$3.62 |
Market Cap | $55.1M |
Shares Short | 896,056 |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | $0 |
Diluted EPS | -$0.42 |
News
See moreYahoo Finance • 3 months ago
Context Therapeutics rises on FDA fast track status for lead asset
Yahoo Finance • 6 months ago
Cancer Drug Developers Secure Regulatory Clarity as FDA Reshapes Approval Standards
Yahoo Finance • 7 months ago
Context Therapeutics Highlights CT-95 and CT-202 Programs at 2025 SITC Annual Meeting
Yahoo Finance • 7 months ago
Context Therapeutics GAAP EPS of -$0.10 misses by $0.01
About
CEO | Mr. Martin A. Lehr |
CFO | Ms. Jennifer Minai-Azary |
Address | 2001 Market Street, Philadelphia, PA, United States, 19103 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 15 |